Timbie Thomas E's Form 4 filing
Treace Medical Concepts, Inc. (TMCI) · filed Nov 22, 2022
- Accession no.
- 0001209191-22-058549
- Filed
- Nov 22, 2022
- Trade date
- Nov 18-22, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.13M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Timbie Thomas ECIK 0001188309 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2022 | Common Stock | SSaleDisposed | −37,605 | $22.66 | −$852,129.3 | 1,361,464 | Indirect | |
| Nov 18, 2022 | Common Stock | SSaleDisposed | −2,101 | $23.46 | −$49,289.46 | 1,359,363 | Indirect | |
| Nov 21, 2022 | Common Stock | SSaleDisposed | −224 | $22.08 | −$4,945.92 | 1,359,139 | Indirect | |
| Nov 22, 2022 | Common Stock | SSaleDisposed | −10,070 | $22.11 | −$222,647.7 | 1,349,069 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.